Skip to Main Content

Paper Details

Pathway Alterations in Stage II/III Primary Melanoma.
JCO Precis Oncol
1
2023
-, Cancer, PI3K, RAS, RTK, Stage II/III Primary Melanoma, TP53, cancer, genes, melanoma, stage II/III primary melanomas
Author NameAffiliation
Arshi AroraMemorial Sloan Kettering Cancer Center
Sharon N EdmistonDepartment of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina
Kathleen ConwayDepartment of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina
Kathleen ConwayUniversity of North Carolina
Ronglai ShenMemorial Sloan Kettering Cancer Center
  • 1 - 5

Datasets

Release 1.2